協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/05/18 | 2,043 | 2,079 | 2,035 | 2,051 | -25 | -1.2% | 1,615,600 |
| 2017/05/17 | 2,070 | 2,087 | 2,063 | 2,076 | +18 | +0.9% | 1,521,600 |
| 2017/05/16 | 2,049 | 2,063 | 2,039 | 2,058 | +13 | +0.6% | 1,001,100 |
| 2017/05/15 | 2,021 | 2,056 | 2,013 | 2,045 | +2 | +0.1% | 1,329,900 |
| 2017/05/12 | 2,043 | 2,055 | 2,029 | 2,043 | +8 | +0.4% | 1,925,400 |
| 2017/05/11 | 2,038 | 2,041 | 2,017 | 2,035 | -14 | -0.7% | 1,278,000 |
| 2017/05/10 | 2,019 | 2,053 | 2,013 | 2,049 | +36 | +1.8% | 2,152,100 |
| 2017/05/09 | 1,987 | 2,023 | 1,981 | 2,013 | +22 | +1.1% | 1,880,000 |
| 2017/05/08 | 1,951 | 2,000 | 1,947 | 1,991 | +49 | +2.5% | 2,057,900 |
| 2017/05/02 | 1,923 | 1,945 | 1,918 | 1,942 | +7 | +0.4% | 1,397,500 |
| 2017/05/01 | 1,910 | 1,936 | 1,889 | 1,935 | +23 | +1.2% | 1,146,400 |
| 2017/04/28 | 1,920 | 1,947 | 1,904 | 1,912 | +11 | +0.6% | 1,657,300 |
| 2017/04/27 | 1,896 | 1,917 | 1,890 | 1,901 | +5 | +0.3% | 1,382,100 |
| 2017/04/26 | 1,896 | 1,916 | 1,877 | 1,896 | +5 | +0.3% | 1,562,700 |
| 2017/04/25 | 1,882 | 1,894 | 1,871 | 1,891 | +5 | +0.3% | 2,569,900 |
| 2017/04/24 | 1,900 | 1,912 | 1,875 | 1,886 | -4 | -0.2% | 2,625,900 |
| 2017/04/21 | 1,876 | 1,909 | 1,863 | 1,890 | +63 | +3.4% | 3,485,800 |
| 2017/04/20 | 1,821 | 1,850 | 1,803 | 1,827 | +2 | +0.1% | 2,940,300 |
| 2017/04/19 | 1,845 | 1,898 | 1,800 | 1,825 | +100 | +5.8% | 4,664,600 |
| 2017/04/18 | 1,694 | 1,731 | 1,685 | 1,725 | +31 | +1.8% | 1,106,400 |
| 2017/04/17 | 1,649 | 1,696 | 1,642 | 1,694 | +28 | +1.7% | 601,400 |
| 2017/04/14 | 1,729 | 1,729 | 1,660 | 1,666 | -23 | -1.4% | 1,433,200 |
| 2017/04/13 | 1,699 | 1,705 | 1,687 | 1,689 | -24 | -1.4% | 928,300 |
| 2017/04/12 | 1,706 | 1,715 | 1,690 | 1,713 | -12 | -0.7% | 937,600 |
| 2017/04/11 | 1,712 | 1,735 | 1,707 | 1,725 | ±0 | ±0% | 1,206,000 |
| 2017/04/10 | 1,731 | 1,743 | 1,705 | 1,725 | +10 | +0.6% | 1,183,600 |
| 2017/04/07 | 1,700 | 1,738 | 1,700 | 1,715 | +31 | +1.8% | 1,456,700 |
| 2017/04/06 | 1,706 | 1,711 | 1,680 | 1,684 | -30 | -1.8% | 1,064,500 |
| 2017/04/05 | 1,710 | 1,728 | 1,707 | 1,714 | +12 | +0.7% | 1,213,300 |
| 2017/04/04 | 1,735 | 1,743 | 1,695 | 1,702 | -53 | -3% | 1,906,600 |
| 2017/04/03 | 1,770 | 1,772 | 1,746 | 1,755 | -7 | -0.4% | 1,208,000 |
| 2017/03/31 | 1,763 | 1,781 | 1,755 | 1,762 | +23 | +1.3% | 1,560,400 |
| 2017/03/30 | 1,777 | 1,778 | 1,734 | 1,739 | -41 | -2.3% | 1,004,900 |
| 2017/03/29 | 1,767 | 1,788 | 1,765 | 1,780 | +20 | +1.1% | 1,194,900 |
| 2017/03/28 | 1,765 | 1,781 | 1,743 | 1,760 | +12 | +0.7% | 1,270,200 |
| 2017/03/27 | 1,757 | 1,762 | 1,742 | 1,748 | -20 | -1.1% | 1,271,800 |
| 2017/03/24 | 1,722 | 1,773 | 1,715 | 1,768 | +59 | +3.5% | 1,139,300 |
| 2017/03/23 | 1,687 | 1,712 | 1,678 | 1,709 | +27 | +1.6% | 662,900 |
| 2017/03/22 | 1,681 | 1,698 | 1,678 | 1,682 | -35 | -2% | 812,500 |
| 2017/03/21 | 1,704 | 1,722 | 1,695 | 1,717 | -9 | -0.5% | 727,800 |
| 2017/03/17 | 1,738 | 1,738 | 1,721 | 1,726 | -24 | -1.4% | 818,800 |
| 2017/03/16 | 1,745 | 1,764 | 1,743 | 1,750 | -12 | -0.7% | 871,700 |
| 2017/03/15 | 1,761 | 1,766 | 1,751 | 1,762 | +3 | +0.2% | 557,800 |
| 2017/03/14 | 1,759 | 1,764 | 1,748 | 1,759 | +5 | +0.3% | 601,300 |
| 2017/03/13 | 1,742 | 1,760 | 1,730 | 1,754 | +6 | +0.3% | 538,900 |
| 2017/03/10 | 1,733 | 1,757 | 1,729 | 1,748 | +50 | +2.9% | 1,630,900 |
| 2017/03/09 | 1,717 | 1,726 | 1,688 | 1,698 | +2 | +0.1% | 861,000 |
| 2017/03/08 | 1,715 | 1,715 | 1,691 | 1,696 | -29 | -1.7% | 848,200 |
| 2017/03/07 | 1,737 | 1,742 | 1,721 | 1,725 | -12 | -0.7% | 921,400 |
| 2017/03/06 | 1,740 | 1,741 | 1,722 | 1,737 | -8 | -0.5% | 782,600 |
1951～
2000
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 216,100円 | -3.5% | -11.3% | 2.78% | 19.85倍 | 1.33倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 218,300円 | +20.9% | +10.6% | 3.02% | 10.31倍 | 1.36倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 386,500円 | +1.7% | -2.9% | 4.14% | 25.36倍 | 1.33倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 148,600円 | +0.6% | +43.3% | 5.38% | 10.41倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
